More recently, we conducted an exome-wide study on the molecular characterization of TP53-mutated high-grade endometrial tumors diagnosed in Martinique, which also detected CCNE1 amplification in 70% of tumors analyzed14. The gene discussed is CCNE1; the disease is endometrium neoplasm.